Price Chart

Key Stats

Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
1.26% -0.22% 1.125B 3.167M
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (Since Inception)
0.30% 83.00% 184.13M Upgrade

Basic Info

Investment Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class Miscellaneous
Broad Category Miscellaneous
Category Name Trading--Leveraged Equity
Category Index S&P 500 TR USD
Global Category Name Trading Tools
YCharts Categorization Other
YCharts Benchmark S&P 500 Total Return (^SPXTR)
Prospectus Objective Specialty - Technology
Fund Owner Firm Name Direxion Funds
Prospectus Benchmark Index
S&P Biotechnology Select Industry TR USD 300.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Paul Brigandi 8.69 yrs
Tony Ng 8.35 yrs

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of February 22, 2024. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Loading chart...
Name
2017
2018
2019
2020
2021
2022
2023
YTD
149.1%
-57.60%
75.51%
74.66%
-64.15%
-80.36%
-13.42%
10.54%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
26.29%
6.87%
-75.67%
-6.26%
-70.81%
-89.74%
1.86%
-32.66%
-41.77%
-18.68%
141.7%
-39.06%
231.9%
69.99%
118.8%
-85.66%
227.0%
31.91%
124.8%
-24.02%
185.6%
69.37%
112.8%
-74.32%
203.1%
17.76%
44.35%
-14.62%
63.45%
21.53%
60.57%
-38.98%
46.66%
12.56%
As of February 22, 2024.

Asset Allocation

As of February 21, 2024.
Type % Net % Long % Short
Cash 6.44% Upgrade Upgrade
Stock 86.08% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 7.48% Upgrade Upgrade

Basic Info

Investment Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class Miscellaneous
Broad Category Miscellaneous
Category Name Trading--Leveraged Equity
Category Index S&P 500 TR USD
Global Category Name Trading Tools
YCharts Categorization Other
YCharts Benchmark S&P 500 Total Return (^SPXTR)
Prospectus Objective Specialty - Technology
Fund Owner Firm Name Direxion Funds
Prospectus Benchmark Index
S&P Biotechnology Select Industry TR USD 300.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Paul Brigandi 8.69 yrs
Tony Ng 8.35 yrs

Top Portfolio Holders

0 of 0